Qube Research & Technologies (QRT)
ONC

Qube Research & Technologies (QRT)’s BeOne Medicines Ltd ONC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.2M Buy
+81,279
New +$24M 0.02% 845
2026
Q1 		– Sell
-94,848
Closed -$28.8M – 4254
2025
Q4 		$28.8M Buy
94,848
+32,456
+52% +$10.6M 0.03% 730
2025
Q3 		$21.3M Sell
62,392
-45,154
-42% -$13.7M 0.02% 863
2025
Q2 		$26M Buy
107,546
+72,317
+205% +$17.7M 0.03% 746
2025
Q1 		$9.59M Buy
35,229
+20,036
+132% +$4.68M 0.01% 1166
2024
Q4 		$2.81M Buy
+15,193
New +$3.1M ﹤0.01% 1743
2024
Q2 		– Sell
-2,533
Closed -$396K – 4886
2024
Q1 		$396K Sell
2,533
-1,866
-42% -$300K ﹤0.01% 2661
2023
Q4 		$793K Buy
4,399
+4,126
+1,511% +$746K ﹤0.01% 2049
2023
Q3 		$49.1K Sell
273
-22,931
-99% -$4.54M ﹤0.01% 2872
2023
Q2 		$4.14M Buy
23,204
+9,989
+76% +$2.3M 0.02% 755
2023
Q1 		$2.85M Buy
+13,215
New +$3.17M 0.01% 857
2022
Q3 		– Sell
-34,589
Closed -$5.6M – 3137
2022
Q2 		$5.6M Buy
+34,589
New +$5.4M 0.04% 467
2021
Q4 		– Sell
-6,375
Closed -$2.31M – 3052
2021
Q3 		$2.31M Sell
6,375
-10,656
-63% -$3.48M 0.03% 635
2021
Q2 		$5.84M Buy
+17,031
New +$5.64M 0.07% 356
2020
Q2 		– Sell
-5,835
Closed -$718K – 2052
2020
Q1 		$718K Sell
5,835
-9,150
-61% -$1.43M 0.03% 468
2019
Q4 		$2.48M Buy
+14,985
New +$2.49M 0.08% 304
2019
Q1 		– Sell
-5,800
Closed -$814K – 478
2018
Q4 		$814K Buy
+5,800
New +$769K 0.35% 57

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ONC Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 81,279 shares worth $23.2M. The stake represents 0.02% of the portfolio and ranks #845 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in ONC as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in ONC in Q4 2018 and has held it in 17 quarters since. The position peaked at $28.8M in Q4 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Qube Research & Technologies (QRT) held 81,279 shares of BeOne Medicines Ltd worth $23.2M as of Q2 2026.
  • BeOne Medicines Ltd was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • BeOne Medicines Ltd made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #845 holding.
  • Qube Research & Technologies (QRT) first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 17 quarters since.
  • Qube Research & Technologies (QRT)'s BeOne Medicines Ltd position peaked at $28.8M in Q4 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.